Shah, Ravi V <br/><br/>
Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure.  [electronic resource] 

 -  The American journal of cardiology  Sep 2012 
 - 683-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1913 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2012.04.056  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Cardiac Resynchronization Therapy--methods<br/>Case-Control Studies<br/>Confidence Intervals<br/>Defibrillators, Implantable<br/>Diabetes Mellitus, Type 2--blood<br/>Disease Progression<br/>Disease-Free Survival<br/>Echocardiography, Doppler--methods<br/>Female<br/>Follow-Up Studies<br/>Glycated Hemoglobin--metabolism<br/>Heart Failure, Systolic--complications<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Retrospective Studies<br/>Risk Assessment<br/>Severity of Illness Index<br/>Statistics, Nonparametric<br/>Survival Analysis<br/>Treatment Outcome